Hsp90β inhibition modulates nitric oxide production and nitric oxide-induced apoptosis in human chondrocytes

Valentina Calamia1, Maria C de Andrés, Natividad Oreiro

  • 1Rheumatology Division, ProteoRed/ISCIII Proteomic Group, INIBIC - Hospital Universitario A Coruña, As Xubias S/N, 15006 - A Coruña, Spain.

Abstract

Insights

Heat shock protein 90 beta (Hsp90β) influences nitric oxide (NO) production and NO-mediated cell death in osteoarthritis (OA) chondrocytes. Inhibiting Hsp90β reduces NO levels and apoptosis in OA cells.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Heat shock protein 90 beta (Hsp90β) is a chaperone protein involved in cellular signaling.
  • Its role in chondrocytes and osteoarthritis (OA) pathogenesis is not fully understood.
  • Hsp90β levels are elevated in osteoarthritic cells.

Purpose of the Study:

  • To investigate the role of Hsp90β in key aspects of OA pathogenesis.
  • To explore Hsp90β's modulation of nitric oxide (NO) production.
  • To determine Hsp90β's involvement in NO-mediated chondrocyte apoptosis.

Main Methods:

  • Human OA chondrocytes were isolated and cultured.
  • Cells were stimulated with pro-inflammatory cytokines and NO donors.
  • Hsp90β was inhibited using chemical inhibitors (Geldanamycin, Novobiocin) or siRNA.
  • Gene expression, apoptosis, and NO production were quantified.

Main Results:

  • Pro-inflammatory cytokines increased Hsp90β expression in chondrocytes.
  • Hsp90β inhibition dose-dependently decreased IL-1β-induced NO production.
  • NO donors also increased Hsp90β levels.
  • Inhibition or silencing of Hsp90β reduced NO-induced apoptosis in chondrocytes.

Conclusions:

  • Hsp90β plays a significant role in modulating NO production in OA chondrocytes.
  • Hsp90β is involved in NO-mediated cellular death pathways in OA chondrocytes.
  • Targeting Hsp90β may offer a therapeutic strategy for OA.